312 related articles for article (PubMed ID: 23152809)
1. Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.
Scherpenisse M; Mollers M; Schepp RM; Boot HJ; Meijer CJ; Berbers GA; van der Klis FR; de Melker HE
PLoS One; 2012; 7(11):e48807. PubMed ID: 23152809
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of seven high-risk HPV types in The Netherlands.
Scherpenisse M; Mollers M; Schepp RM; Boot HJ; de Melker HE; Meijer CJ; Berbers GA; van der Klis FR
Vaccine; 2012 Oct; 30(47):6686-93. PubMed ID: 22959981
[TBL] [Abstract][Full Text] [Related]
3. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands.
Vos RA; Pasmans H; Tymchenko L; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; de Melker HE; van der Klis FRM
Vaccine; 2020 Mar; 38(13):2816-2826. PubMed ID: 32088019
[TBL] [Abstract][Full Text] [Related]
4. Estimating seroprevalence of human papillomavirus type 16 using a mixture model with smoothed age-dependent mixing proportions.
Vink MA; van de Kassteele J; Wallinga J; Teunis PF; Bogaards JA
Epidemiology; 2015 Jan; 26(1):8-16. PubMed ID: 25380503
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study.
Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y
Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521
[TBL] [Abstract][Full Text] [Related]
6. Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program.
Učakar V; Jelen MM; Faust H; Poljak M; Dillner J; Klavs I
Vaccine; 2013 Oct; 31(43):4935-9. PubMed ID: 23994822
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Human Papillomavirus 6/11/16/18 Among Self-identified Gay/Bisexual Men Who Have Sex With Men, Men Who Have Sex With Women, and Females, United States, 2003-2010.
Lewis RM; Markowitz LE; Panicker G; Unger ER
Clin Infect Dis; 2019 Aug; 69(6):1011-1018. PubMed ID: 30475987
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
9. A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
Vink MA; Berkhof J; van de Kassteele J; van Boven M; Bogaards JA
PLoS One; 2016; 11(8):e0161109. PubMed ID: 27537200
[TBL] [Abstract][Full Text] [Related]
10. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children.
af Geijersstam V; Eklund C; Wang Z; Sapp M; Schiller JT; Dillner J; Dillner L
Int J Cancer; 1999 Feb; 80(4):489-93. PubMed ID: 9935145
[TBL] [Abstract][Full Text] [Related]
11. A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.
Wentzensen N; Rodriguez AC; Viscidi R; Herrero R; Hildesheim A; Ghosh A; Morales J; Wacholder S; Guillen D; Alfaro M; Safaeian M; Burk RD; Schiffman M
J Infect Dis; 2011 Jul; 204(1):94-102. PubMed ID: 21628663
[TBL] [Abstract][Full Text] [Related]
12. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses.
Scherpenisse M; Schepp RM; Mollers M; Meijer CJ; Berbers GA; van der Klis FR
PLoS One; 2013; 8(9):e74797. PubMed ID: 24058629
[TBL] [Abstract][Full Text] [Related]
14. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women.
Ng K; Morais S; Wissing MD; Burchell AN; Tellier P-P; Coutlée F; Waterboer T; El-Zein M; Franco EL
Microbiol Spectr; 2024 Jun; 12(6):e0022924. PubMed ID: 38687066
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in HPV immunity among adults without cancer.
Windon MJ; Waterboer T; Hillel AT; Chien W; Best S; Stewart C; Akst L; Troy T; Bender N; Miles B; Ryan WR; Mandal R; Pitman K; Eisele DW; Fakhry C; D'Souza G
Hum Vaccin Immunother; 2019; 15(7-8):1935-1941. PubMed ID: 30650013
[TBL] [Abstract][Full Text] [Related]
17. Changes in HPV Seroprevalence from an Unvaccinated toward a Girls-Only Vaccinated Population in the Netherlands.
Pasmans H; Hoes J; Tymchenko L; de Melker HE; van der Klis FRM
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2243-2254. PubMed ID: 32856612
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.
Rahman S; Pierce Campbell CM; Rollison DE; Wang W; Waterboer T; Michel A; Pawlita M; Villa LL; Lazcano Ponce E; Borenstein AR; Giuliano AR
PLoS One; 2016; 11(11):e0167173. PubMed ID: 27902759
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam.
Heiligenberg M; Michael KM; Kramer MA; Pawlita M; Prins M; Coutinho RA; Dukers-Muijrers NH; Waterboer T
Sex Transm Dis; 2010 Nov; 37(11):672-80. PubMed ID: 20729796
[TBL] [Abstract][Full Text] [Related]
20. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
